Live Evaluations
FC24: Managing Generalized Pustular Psoriasis from Flare to Maintenance: Optimizing Patient Outcomes: An Online Activity
About
Managing Generalized Pustular Psoriasis from Flare to Maintenance: Optimizing Patient Outcomes: An Online Activity
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Learning Objectives
At the completion of this activity, participants should be better able to:
Review the latest clinical data on new and emerging interleukin (IL)-36 inhibitors for treating and preventing generalized pustular psoriasis (GPP) flares
Discuss strategies to counsel patients on trigger avoidance, identifying flares, and flare prevention in GPP
Intended Audience
Faculty
Boni Elewski, MD
James Elder Professor and Chair of Dermatology
University of Alabama at Birmingham
Birmingham, AL
Bruce Strober, MD, PhD
Clinical Professor of Dermatology Yale University
Department of Dermatology
New Haven, CT
Central Connecticut Dermatology
Cromwell, CT
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: Ortho Dermatology
Consultant: Ortho Dermatology
Consultant: AbbVie, Alumis, Almirall, Amgen, Arcutis, Arena, Aristea, Asana, Boehringer Ingelheim, Immunic Therapeutics, Bristol-Myers-Squibb, Connect Biopharma, Dermavant, EPI Health, Evelo Biosciences, Janssen, Leo, Eli Lilly, Maruho, Meiji Seika Pharma, Mindera Health, Novartis, Pfizer, UCB Pharma, Sun Pharma, Regeneron, Sanofi-Genzyme, Union Therapeutics, Ventyxbio, vTv Therapeutics
Speakers’ Bureau or Honoraria: AbbVie, Eli Lilly, Incyte, Janssen, Regeneron, Sanofi-Genzyme
Scientific Co-Director (consulting fee): CorEvitas (formerly Corrona) Psoriasis Registry
Investigator: Dermavant, AbbVie, CorEvitas Psoriasis Registry, Dermira, Cara, Novartis
Editor-in-Chief (honorarium): Journal of Psoriasis and Psoriatic Arthritis
Ownership Interest: Connect Biopharma
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.